Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1990 1
1994 1
1997 1
2001 4
2002 2
2003 2
2004 3
2006 3
2007 1
2008 2
2009 3
2014 2
2015 2
2016 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
Mai EK, Goldschmid H, Miah K, Bertsch U, Besemer B, Hänel M, Krzykalla J, Fenk R, Schlenzka J, Munder M, Dürig J, Blau IW, Huhn S, Hose D, Jauch A, Kunz C, Mann C, Weinhold N, Scheid C, Schroers R, von Metzler I, Schieferdecker A, Thomalla J, Reimer P, Mahlberg R, Graeven U, Kremers S, Martens UM, Kunz C, Hensel M, Benner A, Seidel-Glätzer A, Weisel KC, Raab MS, Salwender HJ; German-speaking Myeloma Multicenter Group (GMMG) HD6 investigators. Mai EK, et al. Lancet Haematol. 2024 Feb;11(2):e101-e113. doi: 10.1016/S2352-3026(23)00366-6. Lancet Haematol. 2024. PMID: 38302221 Free article. Clinical Trial.
Explosive outbursts associated with methylphenidate.
Adrian N. Adrian N. J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):618-9. doi: 10.1097/00004583-200106000-00002. J Am Acad Child Adolesc Psychiatry. 2001. PMID: 11392335 No abstract available.
Structure-activity profiles of Ab-derived TNF fusion proteins.
Bauer S, Adrian N, Fischer E, Kleber S, Stenner F, Wadle A, Fadle N, Zoellner A, Bernhardt R, Knuth A, Old LJ, Renner C. Bauer S, et al. Among authors: adrian n. J Immunol. 2006 Aug 15;177(4):2423-30. doi: 10.4049/jimmunol.177.4.2423. J Immunol. 2006. PMID: 16888004
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg.
Bauer S, Oosterwijk-Wakka JC, Adrian N, Oosterwijk E, Fischer E, Wüest T, Stenner F, Perani A, Cohen L, Knuth A, Divgi C, Jäger D, Scott AM, Ritter G, Old LJ, Renner C. Bauer S, et al. Among authors: adrian n. Int J Cancer. 2009 Jul 1;125(1):115-23. doi: 10.1002/ijc.24359. Int J Cancer. 2009. PMID: 19384924 Free article.
Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma.
Viardot A, Goebeler ME, Hess G, Neumann S, Pfreundschuh M, Adrian N, Zettl F, Libicher M, Sayehli C, Stieglmaier J, Zhang A, Nagorsen D, Bargou RC. Viardot A, et al. Among authors: adrian n. Blood. 2016 Mar 17;127(11):1410-6. doi: 10.1182/blood-2015-06-651380. Epub 2016 Jan 11. Blood. 2016. PMID: 26755709 Free PMC article. Clinical Trial.
26 results